medigraphic.com
SPANISH

Revista Waxapa

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2011, Number 4

<< Back Next >>

waxapa 2011; 3 (4)

Presence of maternal anti-dengue IgG antibodies in a group of newborns in Colima, México

Espinoza-Gómez F, Osuna RJF, Newton-Sánchez OA, Delgado EI, De La Cruz RM, Melnikov V
Full text How to cite this article

Language: Spanish
References: 8
Page: 15-19
PDF size: 88.86 Kb.


Key words:

dengue, maternal IgG antibodies, newborns.

ABSTRACT

Dengue epidemics remain as a priority public health problem especially in tropical countries. Mainly the presence of dengue hemorrhagic fever or other severe forms of the disease represent the greatest social and economic burdens to affected populations. These costs are even greater when dealing with younger populations, as occurs in Southeast Asian countries where rates of severe dengue are highest amongst newborns and little infants. One possible explanation for this phenomenon is that a high proportion of mothers sensitized against dengue transfers the immunoglobulin (IgG) antibodies to their products, which provide partial protection against the specific serotype that were exposed, but, on the other hand, this partial immunization induces a mechanism named antibody enhanced captation of the virus, wich provoke the severe forms of dengue in the presence of secondary infection. In order to explore the frequency of transfer of anti-dengue IgG antibodies to newborns in a hyperendemic area such as Manzanillo, Colima, we analyzed the serum of 66 newborns and from 144 mothers, finding a frequency of 24.4% and 18.4% respectively, confirming the transfer of maternal IgG antibodies to child, although in a much smaller proportion than that found in Asia, which could explain why in Mexico, newborns and young children are not the most affected by the severe forms of dengue.


REFERENCES

  1. WHO. Sthregthening implementation of the global strategy for dengue fever/dengue hemorrhagic fever, prevention and control. WHO/CDS/(DEN)/1C/2000.1. Geneva 18-20 October 1999.

  2. Sistema Único de Información para la Vigilancia Epidemiológica. (2010). Información preliminar, semana 33. Disponible en: http://www.dgepi.salud.gob.mx/boletin/2010/sem33/pdf/cua7.1.pdf

  3. Halstead SB. Epidemiology of dengue and dengue hemorrhagic fever. In Gubler DJ, Kuno G, eds. Dengue and dengue hemorrhagic fever. Wallingford, UK: CAB International, 1997:1-22.

  4. Rigau PJG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Eduard J, Vorndam AV. Dengue and dengue hemorrhagic fever. Lancet 1998; 352 (9132): 971-977.

  5. Pengsaa K, Limkittikul K, Yoksan S, Wisetsing P, Sabchareon A. Dengue antibody in Thai children from maternally transferred antibody to acquired infection. Pediatr Infect Dis J 2011; 30(10):897-900.

  6. Groen G, Koraka P, Velzing J, Copra C, Osterhaus ADM. Evaluation of six Immunoassays for detection of dengue virus-specific Immunoglobulin M and G antibodies. Clin Diagn Lab Immunol 2000; 7: 867–871

  7. Xunta de Galicia y Organización Panamericana de la Salud. Programa para análisis epidemiológico de datos tabulados, EPIDAT versión 3.1. OPS-OMS, Washington DC, USA; 2002.

  8. Isturiz RE, Gubler DJ, del Castillo JB. Dengue and dengue hemorrhagic fever in Latin America and the Caribbean. Infect Dis Clin North Am 2000; 14(1):121-40.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

waxapa. 2011;3